I agree that this site is using cookies. You can find further informations here.
X
Sherbenou, Daniel W.
77  results:
Search for persons X
?
1

Ex Vivo Efficacy of SAR442257 Anti-CD38 Trispecific T-cell ..:

Keller, Alana L. ; Reiman, Lauren T. ; Perez de Acha, Olivia...
Cancer Research Communications.  4 (2024)  3 - p. 757-764 , 2024
Link: https://doi.org/10.1158/..
 
?
2

Lysosomal acid lipase A modulates leukemia stem cell respon..:

Minhajuddin, Mohd ; Winters, Amanda ; Ye, Haobin...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
3

CD38 antibody re-treatment in daratumumab-refractory multip..:

Perez de Acha, Olivia ; Reiman, Lauren ; Jayabalan, David S....
Blood Advances.  7 (2023)  21 - p. 6430-6440 , 2023
Link: https://doi.org/10.1182/..
 
?
4

CD46–ADC Reduces the Engraftment of Multiple Myeloma Patien..:

VanWyngarden, Michael J. ; Walker, Zachary J. ; Su, Yang...
Cancers.  15 (2023)  22 - p. 5335 , 2023
Link: https://doi.org/10.3390/..
 
?
5

Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a ..:

Keller, Alana L. ; Sherbenou, Daniel W. ; Forsberg, Peter A..
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
6

Lenalidomide‐induced autoimmune enteropathy complicating tr..:

Lakritz, Stephanie ; Forsberg, Peter A. ; Sherbenou, Daniel W..
Clinical Case Reports.  10 (2022)  9 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
7

309 MYC Inhibition Overcomes IMiD Resistance in Heterogeneo..:

Davis, Lorraine ; Walker, Zachary J. ; Ohlstrom, Denis...
Journal of Clinical and Translational Science.  6 (2022)  s1 - p. 54-54 , 2022
Link: https://doi.org/10.1017/..
 
?
8

Emerging Therapeutic Strategies to Overcome Drug Resistance..:

Davis, Lorraine N. ; Sherbenou, Daniel W.
Cancers.  13 (2021)  7 - p. 1686 , 2021
Link: https://doi.org/10.3390/..
 
?
9

A case for improving frail patient outcomes in multiple mye..:

Reiman, Lauren T. ; Walker, Zachary J. ; Babcock, Lyndsey R....
Aging and Cancer.  2 (2021)  1-2 - p. 6-12 , 2021
Link: https://doi.org/10.1002/..
 
?
10

Measurement of ex vivo resistance to proteasome inhibitors,..:

Sherbenou, Daniel W. ; Jordan, Craig T. ; Mark, Tomer M....
Blood Advances.  4 (2020)  8 - p. 1628-1639 , 2020
Link: https://doi.org/10.1182/..
 
?
11

Disruption of IRE1α through its kinase domain attenuates mu..:

Harnoss, Jonathan M. ; Le Thomas, Adrien ; Shemorry, Anna...
Proceedings of the National Academy of Sciences of the United States of America.  116 (2019)  33 - p. 16420-16429 , 2019
Link: https://www.jstor.org/st..
 
?
12

Phase II study of carfilzomib and dexamethasone therapy for..:

Forsberg, Peter A. ; Rossi, Adriana C. ; Boyer, Angelique...
American Journal of Hematology.  94 (2019)  5 - p. 539-545 , 2019
Link: https://doi.org/10.1002/..
 
?
13

Cell-type specific potent Wnt signaling blockade by bispeci..:

Lee, Nam-Kyung ; Zhang, Yafeng ; Su, Yang...
Scientific Reports.  8 (2018)  1 - p. , 2018
Link: https://doi.org/10.1038/..
 
?
14

Monoclonal Antibodies in Multiple Myeloma: A New Wave of th..:

Sherbenou, Daniel W. ; Mark, Tomer M. ; Forsberg, Peter
Clinical Lymphoma Myeloma and Leukemia.  17 (2017)  9 - p. 545-554 , 2017
Link: https://doi.org/10.1016/..
 
?
15

The development of potential antibody-based therapies for m..:

Sherbenou, Daniel W. ; Behrens, Christopher R. ; Su, Yang...
Blood Reviews.  29 (2015)  2 - p. 81-91 , 2015
Link: https://doi.org/10.1016/..
 
1-15